Abstract: The present invention relates to the processes for preparing glucagon-like peptide-1 (glp-1) receptor agonists and their analogs. The present invention further relates to processes for preparing liraglutide, D-liraglutide, semaglutide and D-semaglutide. The present invention specifically relates to processes for preparing glucagon-like peptide-1 (glp-1) agonist and their analogs, wherein the liraglutide, D-liraglutide, semaglutide and D-semaglutide produced are substantially pure. The present invention also relates to preparation of glucagon-like peptide-1 (glp-1) agonist and their analogs by solid and solution phase method.
| # | Name | Date |
|---|---|---|
| 1 | 202147044845-STATEMENT OF UNDERTAKING (FORM 3) [04-10-2021(online)].pdf | 2021-10-04 |
| 2 | 202147044845-SEQUENCE LISTING(PDF) [04-10-2021(online)].pdf | 2021-10-04 |
| 3 | 202147044845-SEQUENCE LISTING [04-10-2021(online)].txt | 2021-10-04 |
| 4 | 202147044845-POWER OF AUTHORITY [04-10-2021(online)].pdf | 2021-10-04 |
| 5 | 202147044845-FORM 1 [04-10-2021(online)].pdf | 2021-10-04 |
| 6 | 202147044845-DRAWINGS [04-10-2021(online)].pdf | 2021-10-04 |
| 7 | 202147044845-DECLARATION OF INVENTORSHIP (FORM 5) [04-10-2021(online)].pdf | 2021-10-04 |
| 8 | 202147044845-COMPLETE SPECIFICATION [04-10-2021(online)].pdf | 2021-10-04 |
| 9 | 202147044845-FORM-26 [22-02-2022(online)].pdf | 2022-02-22 |
| 10 | 202147044845-FORM 3 [22-02-2022(online)].pdf | 2022-02-22 |
| 11 | 202147044845-Proof of Right [08-03-2022(online)].pdf | 2022-03-08 |
| 12 | 202147044845-FORM 18 [09-03-2023(online)].pdf | 2023-03-09 |